Data as of Friday, October 23, 2026From 500 companies’ SEC filings · refreshed twice a day · Send feedback
Companies / Health Care / Pharmaceuticals

Merck stock buybacks

MRK
$4.2Bbought back in the 12 months to Jun 30, 2026

Merck bought back $4.2B of its stock in the last twelve months, $3.3B more than it paid out in stock compensation. Its share count is down 1.7% from a year earlier.

Stock repurchases by quarter
$0$750M$1.5BQ3 '20Q3 '21Q3 '22Q3 '23Q3 '24Q2 '26
Show as table
PeriodValue
Q3 '20$0
Q4 '20$0
Q1 '21$0
Q2 '21$239M
Q3 '21$583M
Q4 '21$18M
Q1 '22$0
Q2 '22$0
Q3 '22$0
Q4 '22$0
Q1 '23$149M
Q2 '23$338M
Q3 '23$466M
Q4 '23$393M
Q1 '24$122M
Q2 '24$251M
Q3 '24$444M
Q4 '24$489M
Q1 '25$1.2B
Q2 '25$1.3B
Q3 '25$1.3B
Q4 '25$1.3B
Q1 '26$874M
Q2 '26$757M
Diluted shares outstanding
2.47B2.51B2.55BQ3 '20Q3 '21Q3 '22Q3 '23Q3 '24Q3 '25Q2 '26
Show as table
PeriodValue
Q3 '202.54B
Q4 '202.54B
Q1 '212.54B
Q2 '212.54B
Q3 '212.54B
Q4 '212.54B
Q1 '222.54B
Q2 '222.54B
Q3 '222.54B
Q4 '222.55B
Q1 '232.55B
Q2 '232.54B
Q3 '232.55B
Q4 '232.55B
Q1 '242.54B
Q2 '242.54B
Q3 '242.54B
Q4 '242.54B
Q1 '252.53B
Q2 '252.51B
Q3 '252.50B
Q4 '252.49B
Q1 '262.47B
Q2 '262.47B
$757Mlast quarter (Q2 2026)
$3.3Bnet of stock compensation ($892M)
−1.7%diluted shares, 1 year
−1.3%diluted shares, 5 years
$8.3Bdividends, 12 months
26%of free cash flow ($16.1B) spent on buybacks
$0raised by issuing stock, 12 months
2.47Bshares outstanding (Jul 31, 2026)

By fiscal year

Fiscal yearBuybacksDividendsStock payFree cash flowDiluted sharesFiling
2025$5.1B$8.2B$820M$12.4B2.51B10-K
2024$1.3B$7.8B$761M$18.1B2.54B10-K
2023$1.3B$7.4B$645M$9.1B2.55B10-K
2022$0$7.0B$541M$14.7B2.54B10-K
2021$840M$6.6B$479M—2.54B10-K
2020$1.3B$6.2B$441M—2.54B10-K
2019$4.8B$5.7B$388M—2.58B10-K
2018$9.1B$5.2B$348M—2.68B10-K
2017$4.0B$5.2B$312M—2.75B10-K
2016$3.4B$5.1B$300M—2.79B10-K

Questions

Does Merck & Co. buy back its stock?
Merck bought back $4.2B of its stock in the last twelve months, $3.3B more than it paid out in stock compensation. Its share count is down 1.7% from a year earlier.
How much did Merck & Co. spend on buybacks in fiscal 2025?
$5.1B, according to its 10-K for the fiscal year ending Dec 31, 2025.
Is Merck & Co.'s share count going down?
Its diluted share count changed −1.3% over five fiscal years and −1.7% over the last year.

Latest filing used: 10-Q for the period ending Jun 30, 2026, filed Aug 7, 2026 · open on SEC.gov

Other Health Care companies